Mainz is the capital of Rhineland-Palatinate, but its economic significance at world level grew through one company — BioNTech. The mRNA platform that in 2020 changed global pharma originated in Mainz. The city has about 218,000 inhabitants, lies 40 km west of Frankfurt (same geo as Wiesbaden) and is similarly read industrially through the centre of the Hessian triangle. For an integrator, Rhineland-Palatinate is a market dominated by pharma R&D, specialty glass and the BASF Ludwigshafen chemical cluster.
BioNTech — mRNA platform and its supplier sector
BioNTech SE has its headquarters in Mainz-Goldgrube and R&D + production capacities in Marburg, Idar-Oberstein and Frankfurt. For full-scope pharmaceutical production (GMP-layered clean production, lyophilisation, isolated atmosphere) we don't operate — that's a segment dominantly controlled by specialised integrators (Bausch Advanced Technologies, Optima Pharma, Syntegon). Our typological match is in the periphery: structured cabling and IT infrastructure for R&D centres, mechanical subassembly service for hospital and pharmaceutical equipment, automated handling for logistics zones of the biomedical cold-chain.
The mRNA platform has one technologically interesting orbit where we're indirectly close: ultra-low temperature (-80°C) storage and logistics. That's a segment where via our Embraco / Nidec experience from Košice (compressor technology, refrigeration cycles with R600a propane-based refrigerants) we're typologically reachable. For peripheral tasks in cold-chain infrastructure of BioNTech or its suppliers we could operationally operate.
Schott AG — specialty glass for pharma and optics
Schott AG has its main headquarters and main production in Mainz. They make specialty glass for pharmaceutical packaging applications (Fiolax for injection vials), optical and EUV lithographic applications (synchronised with Zeiss Jena), and energy technologies. For the `industry` pillar (Sondermaschinenbau, injection and glass automation) they're typologically matched with what we do for the Krauss-Maffei world, but specifically glass injection is a different domain — high-temperature material exchange, stricter tolerance on bubbles and internal stress. For partial tasks in the Schott supplier chain (mechanical integration, IT infrastructure) we're deliverable.
BASF Ludwigshafen — the EU's largest chemical complex
BASF Ludwigshafen (50 km south of Mainz, technically already on the Rhineland-Palatinate / Baden-Württemberg border) with 39,000 employees is the EU's largest chemical complex and one of the largest in the world. ATEX zones are essentially the defining parameter of the whole site — ten process plants side by side, layers 0/1/2 plus dust 20/21/22, intrinsically safe equipment as default standard, EPL Gb / Db classification by each specific location.
For BASF and similar complexes in Ludwigshafen, Schwarzheide or Antwerp, we don't operate as a full-scope chemical integrator — here Sulzer, Yokogawa, Endress+Hauser, Emerson rule. For peripheral tasks in zones 1 or 2 (mechanical subassembly service, IT infrastructure in administrative zones) we're operationally ready, but we don't yet have references in this segment.
Our closest reference — Uniper Pumpenspeicher Gemünden
In Mainz itself we don't yet operate directly, but in Rhineland-Palatinate we have one close reference — `uniper-pumpenspeicher-gemuenden` from 2022. That was dismantling of a PUKS (Pumpspeicherkraftwerk) unit in Gemünden am Main, which is formally in Bavaria, but the Mainz region stretches here across the borders of Bavaria and Rhineland-Palatinate through the entire Franconian belt. PUKS dismantling was a serious heavy-lift logistics task (relocation of a turbine-generator assembly with full photographic documentation and re-assembly manual).
For a new Mainz project we'd come with the Uniper Gemünden reference plus the broader German industrial orbit (Krauss-Maffei, vacuum-mechatronic, Nolte, Akon). Our main strong field for Rhineland-Palatinate is `industry + automation` in the supplier chain of pharmaceutical and chemical subjects, not direct core pharma/chemistry.
Daimler Buses Mannheim — city transit buses
Daimler Buses (from 2024 EvoBus GmbH) in Mannheim (50 km south of Mainz) produces Mercedes-Benz Citaro and Setra Comfort buses. For `industry + automation` (Sondermaschinenbau for cabs, gearboxes, mechanical integration) we're typologically close. The path to EvoBus runs via the Daimler Truck audited supplier register — a segment where our path runs via a Tier-1 firm already in the register.
LBauO RLP + BetrSichV + DGUV V3
Building decisions in Rhineland-Palatinate follow Landesbauordnung Rheinland-Pfalz (LBauO RLP). Compared to other German Bundesländer, LBauO RLP has a relatively flexible regime for chemical-pharmaceutical fit-outs (especially for Ludwigshafen and Mainz), but a stricter regime for energy infrastructure projects (wind power in the Eifel, hydro on the Moselle). Electrical installations follow VDE 0100, inspections DGUV V3.
Conclusion — Rhineland-Palatinate via the pharma-chemical potential
For Rhineland-Palatinate we're today present via the Uniper Gemünden reference plus via the Frankfurt-Mainz data centre and AI segment (ai-agent-firm-insurance 2025). For a new Mainz demand we can come with this set of references and with standard A1 + ZOLL Meldeportal Mindestlohn documentation — from Prešov it's about a 12-hour drive on D1 / A4 / A3, meaning weekly accommodation for most projects.